StockNews.com began coverage on shares of Seagen (NASDAQ:SGEN – Free Report) in a report released on Wednesday. The firm issued a hold rating on the biotechnology company’s stock. Several other equities analysts also recently issued reports on SGEN. Truist Financial restated a hold rating and issued a $229.00 price objective on shares of Seagen in […]